G.Bissau warns AIDS patients without treatment since coup

November 21, 2012 in HIV & AIDS

HIV-positive people in Guinea Bissau have been without access to treatment since the Global Fund to fight AIDS suspended funding over an April military coup, the west African nation's AIDS boss said Wednesday.

"Our main funders, the Global Fund, suspended " following the April 12 coup, said Joao Jose Silva Monteiro, coordinator of the national secretariat to fight AIDS.

"Our staff and volunteers are no longer being paid and the drugs have dried up," he warned. "Many patients no longer come to us because they are demoralised and are convinced they are going to die."

He stressed that his organisation, which is part of the , did not conduct work of a political nature and appealed for funding to resume.

"One cannot punish it as if it were part of the government," Monteiro said.

According to government figures, Guinea Bissau has an rate of 3.3 percent, one of the highest in western Africa.

The April coup leaders have handed over power to a civilian administration following a transition deal but many of the country's Western partners do not recognise the new authorities and have frozen aid.

(c) 2012 AFP

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Integrating mental health care into HIV care

The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...

HIV & AIDS created 7 hours ago | popularity not rated yet | comments 0

After a decade, global AIDS program looks ahead

(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...

HIV & AIDS created 20 hours ago | popularity not rated yet | comments 0

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

HIV & AIDS created May 19, 2013 | popularity 5 / 5 (1) | comments 0

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

HIV & AIDS created May 18, 2013 | popularity 5 / 5 (2) | comments 0

Peer-referral programs can increase HIV-testing in emergency departments

Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...

HIV & AIDS created May 17, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.